Bioharvest Sciences Stock Revenue
CNVCFDelisted Stock | USD 5.13 0.07 1.35% |
Bioharvest Sciences fundamentals help investors to digest information that contributes to Bioharvest Sciences' financial success or failures. It also enables traders to predict the movement of Bioharvest OTC Stock. The fundamental analysis module provides a way to measure Bioharvest Sciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bioharvest Sciences otc stock.
Bioharvest |
Bioharvest Sciences OTC Stock Revenue Analysis
Bioharvest Sciences' Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Bioharvest Sciences Revenue | 2.1 M |
Most of Bioharvest Sciences' fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bioharvest Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
CompetitionBased on the latest financial disclosure, Bioharvest Sciences reported 2.1 M of revenue. This is 99.97% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The revenue for all United States stocks is 99.98% higher than that of the company.
Bioharvest Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bioharvest Sciences' direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Bioharvest Sciences could also be used in its relative valuation, which is a method of valuing Bioharvest Sciences by comparing valuation metrics of similar companies.Bioharvest Sciences is currently under evaluation in revenue category among its peers.
Bioharvest Fundamentals
Return On Equity | -63.64 | |||
Return On Asset | -0.53 | |||
Profit Margin | (2.69) % | |||
Operating Margin | (2.45) % | |||
Current Valuation | 106.97 M | |||
Shares Outstanding | 460.72 M | |||
Shares Owned By Insiders | 35.15 % | |||
Price To Book | 91.96 X | |||
Price To Sales | 28.13 X | |||
Revenue | 2.1 M | |||
Gross Profit | 670 K | |||
EBITDA | (8.63 M) | |||
Net Income | (9.83 M) | |||
Cash And Equivalents | 1.21 M | |||
Total Debt | 3.97 M | |||
Debt To Equity | 1.62 % | |||
Current Ratio | 0.69 X | |||
Book Value Per Share | (0.01) X | |||
Cash Flow From Operations | (6.79 M) | |||
Earnings Per Share | (0.01) X | |||
Beta | 1.02 | |||
Market Capitalization | 75.88 M | |||
Total Asset | 10.21 M | |||
Z Score | 11.4 | |||
Net Asset | 10.21 M |
About Bioharvest Sciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bioharvest Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bioharvest Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bioharvest Sciences based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Bioharvest Sciences information on this page should be used as a complementary analysis to other Bioharvest Sciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Consideration for investing in Bioharvest OTC Stock
If you are still planning to invest in Bioharvest Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bioharvest Sciences' history and understand the potential risks before investing.
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |